Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77333022 | 7733302 | 2 | F | 20160804 | 20101223 | 20160818 | EXP | GB-JNJFOC-20101206204 | JOHNSON AND JOHNSON | CLARIDGE LC, EKSTEEN B, SMITH A, SHAH T, HOLT AP. ACUTE LIVER FAILURE AFTER ADMINISTRATION OF PARACETAMOL AT THE MAXIMUM RECOMMENDED DAILY DOSE IN ADULTS. BRITISH MEDICAL JOURNAL 11-DEC-2010;341:1269-1270. CLARIDGE LC. AUTHOR^S REPLY. THE BMJ 01-FEB-2011;342:D628. | 32.00 | YR | A | F | Y | 44.00000 | KG | 20160818 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77333022 | 7733302 | 1 | PS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | N | 19872 | UNSPECIFIED | |||||||||
| 77333022 | 7733302 | 2 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | N | 19872 | 4 | G | UNSPECIFIED | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 77333022 | 7733302 | 2 | Alcohol withdrawal syndrome |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 77333022 | 7733302 | HO |
| 77333022 | 7733302 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 77333022 | 7733302 | Acute hepatic failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |